Infectious Diseases 62 Projects
01:31

T cell assays differentiate clinical and subclinical SARS-CoV-2 infections from cross-reactive antiviral responses

Ane Ogbe

0 views • 2 years ago

01:56

Evaluation of nine commercial SARS-CoV-2 immunoassays

Ria Lassaunière

1 views • 2 years ago

01:50

Neutralising antibodies to SARS coronavirus 2 in Scottish blood donors - a pilot study of the value of serology to determine population exposure

Craig P Thompson

0 views • 2 years ago

01:15

A gene locus that controls expression of ACE2 in virus infection

M. Azim Ansari

0 views • 2 years ago

01:29

A systematic review of antibody mediated immunity to coronaviruses: antibody kinetics, correlates of protection, and association of antibody responses with severity of disease

Angkana T. Huang

0 views • 2 years ago

02:17

Lumipulse G SARS-CoV-2 Ag Assay Evaluation for SARS-CoV-2 Antigen Detection Using 594 Nasopharyngeal Swab Samples from Different Testing Groups

Giulia Menchinelli

0 views • 2 years ago

01:29

Detecting Pathogen-Associated RNA via Piecewise Isothermal Testing achieving Sample-to-Result Integration

Saptarshi Banerjee

0 views • 2 years ago

01:49

The SARS-CoV-2 antibody landscape is lower in magnitude for structural proteins, diversified for accessory proteins and stable long-term in children

Asmaa Hachim

0 views • 2 years ago

01:12

Viral mutation, contact rates and testing: a DCM study of fluctuations

Karl Friston

0 views • 2 years ago

01:56

How vaccination and contact isolation might interact to suppress transmission of Covid-19: a DCM study

Karl Friston

0 views • 2 years ago

01:48

Detection of autoimmune antibodies in severe but not in moderate or asymptomatic COVID-19 patients

Aisha D. Fakhro

0 views • 2 years ago

01:48

A phenome-wide association study (PheWAS) of COVID-19 outcomes by race using the electronic health records data in Michigan Medicine

Maxwell Salvatore

0 views • 2 years ago

02:03

History of Coronary Heart Disease Increases the Mortality Rate of Coronavirus Disease 2019 (COVID-19) Patients: A Nested Case-Control Study Based on Publicly Reported Confirmed Cases in Mainland China

Tian Gu

0 views • 2 years ago

03:04

COVID-19 outcomes, risk factors and associations by race: a comprehensive analysis using electronic health records data in Michigan Medicine

Tian Gu

0 views • 2 years ago

01:21

Ultra-Sensitive High-Resolution Profiling of Anti-SARS-CoV-2 Antibodies for Detecting Early Seroconversion in COVID-19 Patients

Maia Norman

0 views • 2 years ago

01:48

Evaluation of two commercial and two non-commercial immunoassays for the detection of prior infection to SARS-CoV-2

Eric James Nilles

0 views • 2 years ago

02:01

Evaluation of serological lateral flow assays for severe acute respiratory syndrome coronavirus-2

Bianca A Trombetta

0 views • 2 years ago

01:13

Ultrasensitive measurement of both SARS-CoV2 RNA and serology from saliva

Dmitry Ter-Ovanesyan

0 views • 2 years ago

01:16

Serial Profiling of SARS-CoV-2 Antigens and Antibodies in COVID-19 Patient Plasma

Alana F. Ogata

0 views • 2 years ago

01:41

More than just smell - COVID-19 is associated with severe impairment of smell, taste, and chemesthesis

Valentina Parma

0 views • 2 years ago

02:57

Postlockdown Dynamics of COVID-19 in New York, Florida, Arizona, and Wisconsin

Shery Scott

0 views • 2 years ago

02:27

Blood-based host biomarker diagnostics in active case finding for pulmonary tuberculosis: a diagnostic accuracy study

Flora Martinez Figueira Moreira

0 views • 2 years ago

01:23

Multi-cohort analysis of host immune response identifies conserved protective and detrimental modules associated with severity irrespective of virus

Hong Zeng

0 views • 2 years ago

00:43

Transcriptomic Similarities and Differences in Host Response between SARS-CoV-2 and Other Viral Infections

Simone A. Thair

0 views • 2 years ago

01:55

COVID-19: Can early home treatment with Azithromycin alone or with Zinc help prevent hospitalisation, death, and long-COVID-19? A review

Philippe LEPERE

0 views • 2 years ago

01:17

Coronavirus Disease 2019 (COVID-19): An Evidence Map of Medical Literature

Nan Liu

0 views • 2 years ago

02:15

Artificial Intelligence Applications for COVID-19 in Intensive Care and Emergency Settings: A Systematic Review

Marcel Lucas Chee

0 views • 2 years ago

01:11

Symptomatic SARS-CoV-2 infections display specific IgG Fc structures

Saborni Chakraborty

0 views • 2 years ago

02:23

Clinical predictors of donor antibody titer and correlation with recipient antibody response in a COVID-19 convalescent plasma clinical trial

Maria Lucia L Madariaga

0 views • 2 years ago

01:40

Rapid homogeneous assay for detecting antibodies against SARS-CoV-2

Juuso Rusanen

0 views • 2 years ago

01:53

Evidence of a significant secretory-IgA-dominant SARS-CoV-2 immune response in human milk following recovery from COVID-19

Alisa Fox

0 views • 2 years ago

01:53

Real Time Investigation of a large Nosocomial Influenza A Outbreak Informed by Genomic Epidemiology

Waleed Javaid

0 views • 2 years ago

01:13

Differential T cell reactivity to seasonal coronaviruses and SARS-CoV-2 in community and health care workers

Ricardo da Silva Antunes

0 views • 2 years ago

00:42

Introductions and early spread of SARS-CoV-2 in the New York City area

Ana S. Gonzalez-Reiche

0 views • 2 years ago

02:42

SARS-CoV-2 seropositivity and subsequent infection risk in healthy young adults: a prospective cohort study

Andrew G Letizia

0 views • 2 years ago

02:31

High Initial Titres of Anti-Spike Antibodies following SARS-CoV-2 Infection is Associated with Faster Decay Rates at Four Months Follow-Up

Vidya Menon

0 views • 2 years ago

02:33

The E484K mutation in the SARS-CoV-2 spike protein reduces but does not abolish neutralizing activity of human convalescent and post-vaccination sera.

Sonia Jangra

0 views • 2 years ago

01:22

Choosing the right tool for the job: A comprehensive assessment of serological assays for SARS-CoV-2 as surrogates for authentic virus neutralization

Nicholas Wohlgemuth

0 views • 2 years ago

01:12

Before the Surge: Molecular Evidence of SARS-CoV-2 in New York City Prior to the First Report

Matthew M. Hernandez

0 views • 2 years ago

02:01

Distinct systems serology features in children, elderly and COVID patients

Kevin J. Selva

0 views • 2 years ago

02:10

The N501Y mutation in SARS-CoV-2 spike leads to morbidity in obese and aged mice and is neutralized by convalescent and post-vaccination human sera

Raveen Rathnasinghe

0 views • 2 years ago

01:17

Seroprevalence of SARS-CoV-2 among children visiting a hospital during the initial Seattle outbreak

Adam S Dingens

0 views • 2 years ago

01:18

The plasmablast response to SARS-CoV-2 mRNA vaccination is dominated by non-neutralizing antibodies that target both the NTD and the RBD

Fatima Amanat

0 views • 2 years ago

02:09

Quantifying absolute neutralization titers against SARS-CoV-2 by a standardized virus neutralization assay allows for cross-cohort comparisons of COVID-19 sera

Kasopefoluwa Y. Oguntuyo

0 views • 2 years ago

01:27

Antibody Immunological Imprinting on COVID-19 Patients

Teresa Aydillo

0 views • 2 years ago

01:52

High attack rates of SARS-CoV-2 infection through household-transmission: a prospective study

Kanika Kuwelker

0 views • 2 years ago

00:58

SARS-CoV-2 infection induces robust, neutralizing antibody responses that are stable for at least three months

Ania Wajnberg

0 views • 2 years ago

00:10

Convalescent plasma treatment of severe COVID-19: A matched control study

Sean T.H. Liu

0 views • 2 years ago

01:36

Humoral immune response and prolonged PCR positivity in a cohort of 1343 SARS-CoV 2 patients in the New York City region

Ania Wajnberg

0 views • 2 years ago

01:10

Neutralizing Antibody Responses in COVID-19 Convalescent Sera

William T Lee

0 views • 2 years ago

01:57

Longitudinal analysis of SARS-CoV-2 seroprevalence using multiple serology platforms

Juan Manuel Carreño

0 views • 2 years ago

01:39

A High Through-put Assay for Circulating Antibodies Directed against the S Protein of Severe Acute Respiratory Syndrome Corona virus 2

Svenja Weiss

0 views • 2 years ago

01:51

Recent smell loss is the best predictor of COVID-19: a preregistered, cross-sectional study

Richard C. Gerkin

0 views • 2 years ago

02:20

The impact of the COVID-19 pandemic on influenza, respiratory syncytial virus, and other seasonal respiratory virus circulation in Canada

Helen E. Groves

0 views • 2 years ago

02:10

Glucocorticoids and B Cell Depleting Agents Substantially Impair Immunogenicity of mRNA Vaccines to SARS-CoV-2

Parakkal Deepak

0 views • 2 years ago

01:39

Integrated immunovirological profiling validates plasma SARS-CoV-2 RNA as an early predictor of COVID-19 mortality

Elsa Brunet-Ratnasingham

0 views • 2 years ago

02:57

Renin-angiotensin system blockers and mortality in COVID-19: a territory-wide study from Hong Kong

Jiandong Zhou

0 views • 2 years ago

02:19

Development of a predictive risk model for severe COVID-19 disease using population-based administrative data

Jiandong Zhou

0 views • 2 years ago

02:17

Identifying main and interaction effects of risk factors to predict intensive care admission in patients hospitalized with COVID-19: a retrospective cohort study in Hong Kong

Jiandong Zhou

0 views • 2 years ago

00:24

Insights into the molecular mechanism of anticancer drug ruxolitinib repurposable in COVID-19 therapy

Manisha Mandal

0 views • 2 years ago

01:18

Detection of transmission change points during unlock-3 and unlock-4 measures controlling COVID-19 in India

Manisha Mandal

0 views • 2 years ago

01:13

Differential gene expression in scrub typhus compared to other acute febrile infections by bioinformatic approaches

Manisha Mandal

0 views • 2 years ago